Mirae Asset Global ETFs Holdings’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
31,865
-456
-1% -$15.3K ﹤0.01% 1571
2026
Q1
$1.16M Buy
32,321
+291
+0.9% +$7.53K ﹤0.01% 1450
2025
Q4
$636K Sell
32,030
-15
-0% -$289 ﹤0.01% 1766
2025
Q3
$585K Sell
32,045
-5,752
-15% -$94.6K ﹤0.01% 1791
2025
Q2
$595K Buy
+37,797
New +$481K ﹤0.01% 1726

Other funds holding CLMT

Mirae Asset Global ETFs Holdings's CLMT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Calumet Specialty Products (CLMT) stake by 1.4% in Q2 2026, selling an estimated $15.3K and leaving 31,865 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Mirae Asset Global ETFs Holdings first reported a position in CLMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.16M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 31,865 shares of Calumet Specialty Products worth $1.15M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 456 Calumet Specialty Products shares in Q2 2026, an estimated $15.3K.
  • Calumet Specialty Products made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1571 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Calumet Specialty Products position peaked at $1.16M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.